ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

... And Sets Up Discovery Venture With Jubilant

by Jean-François Tremblay
October 13, 2008 | APPEARED IN VOLUME 86, ISSUE 41

Lilly and Jubilant Organosys have agreed to form an equally owned drug discovery joint venture in Bangalore, India. Run by a separate management team, the venture will perform preclinical drug discovery and manage tests on human patients up to Phase II clinical trials. Phase III trials and further commercial development will be undertaken either by Lilly or Jubilant. Lilly has been attempting to lower its drug development costs by teaming up with other organizations.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment